Skip to main content
OpenTrials

Clinical trial condition

Adenoma

Explore clinical trials studying Adenoma. Study availability and eligibility vary by location and protocol.

597 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Adenoma trial results

Completed

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

NCT00427349

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations
  • Hematology Oncology Associates of Illinois - Berwyn Berwyn, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Hematology and Oncology Associates Chicago, Illinois, United States
  • Midwest Center for Hematology/Oncology Joliet, Illinois, United States
View all 112 locations
View Trial Details
Completed

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

NCT02899195

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations
  • University San Diego Moores Cancer Center La Jolla, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 20 locations
View Trial Details
Completed

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

NCT00101283

Conditions
Adenoma, Lung Diseases, Lung Neoplasms, +11 more
Locations
  • Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
View all 115 locations
View Trial Details
Completed

A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis

NCT05014360

Conditions
Adenoma, Adenomatous Polyposis Coli, Adenomatous Polyps, +16 more
Locations
  • City of Hope Duarte, California, United States
  • University of Miami Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 16 locations
View Trial Details
Completed

First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express Mesothelin

NCT03507452

Conditions
Adenoma, Advanced Pancreatic Ductal Adenocarcinoma (Optional, Dose Expansion, Not Initiated), Advanced Recurrent Malignant Peritoneal Epithelioid Mesothelioma, +15 more
Locations
  • National Cancer Institute - Maryland Bethesda, Maryland, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • HUS, Meilahden sairaala Helsinki, Finland
  • Nederlands Kanker Instituut Amsterdam, Netherlands
View Trial Details

Related conditions